NCT06414707View on ClinicalTrials.gov

Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori

PHASE3CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

April 4, 2024

Study Completion Date

April 4, 2024

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Vonoprazan, Amoxicillin and Levofloxacin

Group (1) included 160 patients received Vonoprazan 20 mg oral once daily + Levofloxacin 500 mg oral once daily + Amoxicillin 1 gm oral twice daily for 14 days.

DRUG

Pantoprazole 40mg, Amoxicillin and Levofloxacin

Group (2) included 160 patients received Pantoprazole 40 mg oral twice daily + Levofloxacin 500 mg oral once daily + Amoxicillin 1 gm oral twice daily for 14 days.

Trial Locations (1)

3753450

Mostafa Elfors, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06414707 - Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori | Biotech Hunter | Biotech Hunter